German dose form plant ok'd

Just three minor Form 483 observations followed a pre-approval inspection of New Jersey-based Catalent Pharma's integrated dose form development, manufacturing and packaging facility in Schorndorf, Germany. The facility provides formulation and development services as well as clinical and commercial manufacturing for oral tablets and capsules, powders and other dosage forms. Release

Webinar

Using AI and RWD to Uncover Rare Disease Insights, Accelerate Commercialization and Improve Patient Outcomes

Wednesday, March 24 | 2pm ET / 11am PT

Learn how IPM.ai transformed real world data into real world insights to assist Audentes in their development of AT132 for the treatment of XLMTM. The session reviews how IPM.ia and Audentes collaborated to uncover the XLMTM patient population.